Seres to start selling ‘poop pill’ in June at $17,500 per course


Seres Therapeutics Inc. plans to start selling its first FDA-approved product, a drug called Vowst made of bacterial spores derived from donated feces, this summer at $17,500 a course.

Previous HCA Healthcare to spend $4.6 billion on capital expenditures in 2023
Next Longtime surgeon to serve as TriHealth’s first chief health equity officer